Castleview Partners’s KraneShares MSCI All China Health Care Index ETF KURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-18,540
Closed -$646 875
2021
Q4
$646 Buy
+18,540
New +$638K 0.01% 467
2021
Q2
$70K Buy
+1,540
New +$65.5K 0.03% 346

Other funds holding KURE

Castleview Partners's KURE Position: Q1 2022 in Review

Castleview Partners sold out of KraneShares MSCI All China Health Care Index ETF (KURE) in Q1 2022, closing a stake of 18,540 shares — an estimated $646 sold.

Castleview Partners first reported a position in KURE in Q2 2021 and held it in 2 quarters. The position peaked at $70K in Q2 2021. 22 funds tracked by Wall St. Rank hold KURE as of Q1 2022.

  • Castleview Partners reported no remaining KraneShares MSCI All China Health Care Index ETF position as of Q1 2022 after selling out during the quarter.
  • Castleview Partners sold 18,540 KraneShares MSCI All China Health Care Index ETF shares in Q1 2022, an estimated $646.
  • Castleview Partners first reported a position in KraneShares MSCI All China Health Care Index ETF in Q2 2021 and held it in 2 quarters.
  • Castleview Partners's KraneShares MSCI All China Health Care Index ETF position peaked at $70K in Q2 2021.
  • 22 funds tracked by Wall St. Rank held KraneShares MSCI All China Health Care Index ETF as of Q1 2022.

Based on Castleview Partners's 13F filing for Q1 2022, filed 16 May 2022.